Hormonal Associations in Male Patients With Psoriasis Vulgaris

Sex: Male

Ages: 18 Years – 55 Years

Healthy volunteers: 1

Enrollment: 102

Sponsor: Sohag University

Summary

A cross sectional clinical study will be conducted on male patients with moderate and sever psoriasis vulgaris to:Identify the pattern of serum testosterone level and tissue androgen receptors.Evaluate the relationship between serum testosterone level, tissue androgen receptors and the severity of psoriasis vulgaris

Eligibility Criteria

Inclusion Criteria:Cases:Male patients with plaque psoriasis.With clinically moderate to severe plaque psoriasis (PASI score >10).For at least 1 year.Age (18-55) years old.Control:●Healthy male volunteers matched to the patient group for age and sex.Exclusion Criteria:Other clinical varieties of psoriasis.History of diabetes mellitus.History of advanced renal or hepatic disease.History of genital disorders, or hormonal impalance.Current use of hormonal therapy, lipid-reducing drugs, and/or gluco- corticosteroid.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05716152). StuddyBuddy aggregates publicly available trial information.